FIGS.NYSEFigs, INC

Form 4: FIGS Inc. CFO Daniella Turenshine Reports Stock Sale to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Daniella Turenshine, CFO of FIGS, Inc., reports the sale of 15,762 shares of Class A Common Stock to cover tax obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

  • Daniella Turenshine, the Chief Financial Officer of FIGS, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
  • On March 5, 2024, Turenshine sold 15,762 shares of Class A Common Stock at a price of $5.5375 per share.
  • The sale was executed under a pre-arranged 10b5-1 trading plan adopted on November 11, 2021, and was solely to cover tax obligations arising from the vesting and settlement of Restricted Stock Units (RSUs).
  • Following the transaction, Turenshine directly owns 409,858 shares, the majority of which are RSUs representing a contingent right to receive one share of Class A Common Stock.
  • She also beneficially owns 697,283 shares of Class A Common Stock underlying vested options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing relates to a routine stock sale for tax purposes under a pre-existing plan. It doesn't indicate any fundamental change in the company's prospects.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice and regulated by the SEC to ensure transparency and prevent insider trading. The use of a 10b5-1 trading plan is a standard method for insiders to sell shares without raising concerns about trading on non-public information.

Comparison to Industry Standards

  • Form 4 filings are standard practice for corporate insiders and are comparable across all publicly traded companies.
  • The use of 10b5-1 trading plans is a common strategy employed by executives at companies like Nike, Lululemon, and Under Armour to manage their stock sales in a compliant manner.

Stakeholder Impact

  • The stock sale may have a minor dilutive effect on existing shareholders, but it is unlikely to be significant given the relatively small number of shares involved.
  • The transaction ensures the CFO remains compliant with regulations and manages her tax obligations effectively.

Key Dates

DateDescription
2021-11-11Date the 10b5-1 instruction letter was delivered to the issuer.
2024-03-05Date of the transaction (stock sale).
2024-03-07Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.